Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-12-026450
Filing Date
2012-04-19
Accepted
2012-04-19 15:27:15
Documents
3
Period of Report
2012-05-23
Effectiveness Date
2012-04-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A a12-1895_1def14a.htm DEF 14A 961106
2 GRAPHIC g18951cci001.gif GRAPHIC 56661
3 GRAPHIC g18951cci002.gif GRAPHIC 42650
  Complete submission text file 0001104659-12-026450.txt   1099399
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 12768390
SIC: 2834 Pharmaceutical Preparations